|
|
Recent Developments in the Treatment of Clear Cell, Renal Cell Carcinoma: Essential Insights and Updates for the Healthcare Team
Target Audience
Oncology, Managed care and Specialty Pharmacists and Oncology Nurses/Nurse Practitioners
Program Overview
The goal of this educational initiative is to equip oncology nurse practitioners and nurses, as well as oncology, managed care, and specialty care pharmacists with the knowledge to apply findings from risk scoring systems used to stratify cases of clear cell renal cell carcinoma for treatment selection, differentiate among an expanding array of combination regimens con... |
|
|
Psoriasis Prime Time: The Role of TYK Inhibition in Psoriasis
Target Audience
This activity has been designed to address the educational needs of dermatologists, dermatology nurse practitioners, and PAs. It may also be of benefit to primary care clinicians, rheumatologists, and other healthcare practitioners who are interested in the treatment of psoriasis.
Program Overview
In this edition of Psoriasis Prime Time, the faculty reviews the unique mechanism of action for allosteric tyrosine kinase 2 (TYK2) inhibitors compared with Janus kinase inhibito... |
|
|
Practice-Changing Advances in the Management of Hemophilia
STATEMENT OF NEED
Hemophilia is an inherited bleeding disorder in which the blood does not clot properly, causing affected individuals to experience spontaneous bleeding as well as bleeding after injuries or surgery. The 2 most common types are hemophilia A, caused by low levels of clotting factor VIII; and hemophilia B, caused by low levels of clotting factor IX. The standard treatment for hemophilia involves replacing the missing blood clotting factor by infusing commercially prepared facto... |
|
|
Podcast: Practice-Changing Advances in the Management of Hemophilia
STATEMENT OF NEED
Hemophilia is an inherited bleeding disorder in which the blood does not clot properly, causing affected individuals to experience spontaneous bleeding as well as bleeding after injuries or surgery. The 2 most common types are hemophilia A, caused by low levels of clotting factor VIII; and hemophilia B, caused by low levels of clotting factor IX. The standard treatment for hemophilia involves replacing the missing blood clotting factor by infusing commercially prepared facto... |
|
|
29th Annual Hypertension, Diabetes & Dyslipidemia Conference
Combine medical education and southern charm at the 29th Annual Hypertension, Diabetes, & Dyslipidemia Conference, happening from June 18-20, 2025, at the Hyatt Regency in Savannah, GA. Immerse yourself in a dynamic CME-accredited program, garnering 15.25 credits, designed to address the complexities of diabetes, hypertension, and dyslipidemia. Join healthcare professionals in the historic setting of Savannah, where centuries-old tradition will meet modern clinical insights, creating a tru... |
|
|
New Guidelines and Novel Treatments for PAH: Taking a Forward-Looking Data Dive Into the Pool of Emerging Therapies
Target Audience
This educational activity has been designed to meet the needs of cardiologists, pulmonologists, rheumatologists, and other physicians, including those in primary care and internal medicine, as well as physician assistants, nurse practitioners, and other healthcare providers who may be involved in managing care for patients with pulmonary arterial hypertension (PAH).
Program Overview
Discoveries about the pathogenesis of pulmonary arterial hypertension (PAH) revealed key mo... |
|
|
Powder Free Nitrile Gloves Manufacturers in India - Enliva
Enliva offers high-quality Powder Free Nitrile Gloves for healthcare professionals' safety and comfort. Find the best hand safety solutions now! |
|
|
Sharing Real-World Experiences with New Rett Syndrome Therapies
Target Audience
The educational design of this activity addresses the needs of neurologists, pediatric neurologists, and specialty NP/PAs involved in the treatment of patients with Rett syndrome.
Program Overview
Integrating newer agents for the treatment of Rett syndrome into clinical practice can be challenging, particularly in community settings. In this activity, an expert panel will convene featuring a neurologist from an International Rett Syndrome Foundation (IRSF)-designated cente... |
|
|
Distinguishing and Managing Early-Stage Alzheimer’s Disease (AD): Leveraging Interdisciplinary Collaboration for Prompt Identification and Optimal Patient Management
Target Audience
This activity is designed to meet the educational needs of healthcare providers involved in the diagnosis and continued care of patients with Alzheimer’s disease, including neurologists, geriatricians, psychiatrists, primary care physicians, nurses, and other multidisciplinary team members.
Program Overview
This educational activity is designed to provide clinicians who manage patients with Alzheimer’s disease with current information on diagnosis and management, inclu... |
|
|
33rd Annual Primary Care Conference, Session 1
Emmerse yourself in the allure of Kiawah Island, South Carolina, while enhancing your medical expertise at the 33rd Annual Primary Care Conference, CEC's oldest and most popular CME conference. Attend one of two sessions: June 23 - 27 or June 30 - July 4 at the prestigious Kiawah Island Golf Resort. This event allows primary care clinicians to stay updated in rapidly changing therapeutic areas with time to explore Kiawah Island's pristine beaches and lush marshlands, where CEC has be... |
|
|
Myasthenia Gravis Research Highlights: AAN 2024
This accredited CME program highlights the latest clinical research about myasthenia gravis, a rare, autoimmune disease that targets the neuromuscular junction.
Treatment of myasthenia gravis is highly individualized and depends greatly on the myasthenia gravis subtype of each patient as well as each patient’s comorbidities. There are currently five drugs approved by the FDA, eculizumab, efgartigimod, ravulizumab, rozanolixizumab, and zilucoplan. Clinical trial data on these therapies, as... |
|
|
Myasthenia Gravis Research Highlights: AAN 2024
Target Audience
This activity has been designed to meet the educational needs of physicians specializing in neurology, ophthalmology and family practice. Other members of the care team may also participate.
Program Overview
This accredited CME program highlights the latest clinical research about myasthenia gravis, a rare, autoimmune disease that targets the neuromuscular junction.
Treatment of myasthenia gravis is highly individualized and depends greatly on the myasthenia gravis subt... |
|
|
Autosomal Dominant Polycystic Kidney Disease " Understanding the Disease and Improving Treatment Adherence and Outcome
Target Audience
This activity is designed to meet the educational needs of nephrologists, primary care providers, and providers who care for patients with kidney disease.
Program Overview
In the real-world setting, treatment adherence in patients with autosomal dominant polycystic kidney disease (ADPKD) can be a challenge. This CME program will discuss the diagnosis and management of ADPKD as well as strategies on improving treatment adherence. Patients’ perspectives on how to deal with... |
|
|
Lifestyle Medicine: Tools for Promoting Healthy Change - LIVE STREAMING
State-of-the-Art Approaches to Help Patients Initiate and Sustain Health-Promoting Behaviors
Lifestyle Medicine will be held online this year, using live streaming, electronic Q&A, and other remote learning technologies.
Overview
This immersive two-day course offers state-of-the-art strategies to guide patients to healthier lives. Education includes evidence-based strategies, tools and techniques to effect healthier changes in patients (and ourselves), including weight loss, exerci... |
|
|
33rd Annual Primary Care Conference, Session 2
Elevate your medical practice at the 33rd Annual Primary Care Conference, CEC's longest-running and most popular CME event, hosted at the prestigious Kiawah Island Golf Resort. Held during two sessions from June 23 - 27 or June 30 - July 4, you have the flexibility to choose the dates that best fit your schedule.
Prepare for enlightening morning sessions led by expert faculty, covering a comprehensive array of topics tailored to the evolving needs of primary care clinicians. Dive into ... |
|
|
Peripheral Nerve Ultrasound " Blended Course
The Blended Peripheral Nerve Ultrasound Course is designed to provide practical training for mastering peripheral nerve ultrasound and neuromuscular assessment. The Blended Education format provides flexibility while providing time and cost savings.
Begin with the self-paced online course: Taught by leading peripheral nerve and musculoskeletal ultrasound experts, the online course incorporates a comprehensive review of the sonographic anatomy of upper and lower limb peripheral nerves and as... |
|
|
Identifying Needs and Opportunities to Improve Clinical Outcomes in the Identification, Characterization, and Management of Low-Grade Serous Ovarian Cancer
Target Audience
This activity is designed to meet the educational needs of oncologists, obstetrician/gynecologists, gastroenterologists, and primary care physicians to ensure confidence in the diagnosis, characterization, and management of low-grade serous ovarian cancer, including through enrollment in ongoing clinical trials.
Program Overview
This enduring educational activity will provide insight into evidence-based approaches for clinical and pathological assessment of patients with d... |
|
|
Diagnosis and Evidence-based Prevention of Chronic Obstructive Pulmonary Disease Exacerbations
Target Audience
The primary target audience for this activity are Pulmonology clinicians (MDs/DOs/NPs/PAs) based in the U.S.
Program Overview
Many patients do not receive appropriate and timely treatment for chronic obstructive pulmonary disease (COPD) because of underdiagnoses, diagnostic delays, or misdiagnoses as other respiratory conditions such as asthma. An expert panel of pulmonologists will identify and address important gaps in the differential diagnosis and management of COPD. O... |
|
|
Lp(a) and LDL-C Management: Exploring Divergent Perspectives
Target Audience
The intended audience for this activity is cardiologists, endocrinologists, internists, pharmacists, nurses, and other healthcare professionals involved in the management of patients with hyperlipidemia and other cardiovascular risk factors.
Program Overview
Lp(a) and LDL-C Management: Exploring Divergent Perspectives is a continuing education (CE) initiative aimed at broadening healthcare professionals' understanding of the complex nature of hyperlipidemia management... |
|
|
Teaming Up to Treat Rett Syndrome: The Importance of Fostering a Multidisciplinary Approach to Patient Care
Target Audience
The educational design of this activity addresses the needs of neurologists, pediatric neurologists and specialty NP/PAs involved in the treatment of patients with Rett syndrome.
Program Overview
With newer therapies now available for the treatment of Rett syndrome, it is essential that the challenges of managing patients with rare diseases, such as Rett syndrome in resource-poor areas or “care deserts” be addressed.
Join a neurologist and a gastroenterologist from ... |
|
|
PEERx - Ethics Module 3: Importance of Business Ethics to the Pharmacy Community
This Educational Activity is provided by Pharmacy Ethics, Education, and Resources (PEER) and is designed to educate healthcare professionals on ethics to improve patient safety.
Pharmacy presents its own set of challenges. When business is intertwined, it gives rise to numerous ethical dilemmas. This program aims to introduce the ethical principles within the pharmacy and business realms, as well as to outline a robust decision-making framework. By reviewing various scenarios, owners, s... |
|
|
PEERx - Ethics Module 6: Preparing Pharmacy For The Next Crisis
This Educational Activity is provided by Pharmacy Ethics, Education, and Resources (PEER) and is designed to educate healthcare professionals on ethics to improve patient safety.
The emergence of the COVID-19 virus in 2020 plunged the world into an unprecedented pandemic. Pharmacists found themselves at the forefront of this global health emergency, facing it with minimal preparation and guidance. With existing emergency plans proving ineffective during a worldwide shutdown, this initiat... |
|
|
Psoriasis With Scalp Involvement in a Patient With Skin of Color
Target Audience
This activity has been designed to address the educational needs of dermatologists, dermatology nurse practitioners, and PAs. It may also be of benefit to primary care clinicians, rheumatologists, and other healthcare practitioners who are interested in the treatment of psoriasis.
Program Overview
This case will discuss the treatment of psoriasis in patients with skin of color, highlighting the challenges of treating scalp psoriasis. The faculty will review the mechanism o... |
|
|
Comprehensive Management of Von Hippel-Lindau Disease: Genetic and Oncological Perspectives
STATEMENT OF NEED
Von Hippel-Lindau disease (VHL) is an autosomal dominant disease in which germline pathogenic variants in the VHL gene predispose individuals to specific types of benign tumors, malignant tumors, and cysts in multiple organs, including clear cell renal cell carcinoma (RCC), renal cysts, central nervous system hemangioblastomas, retinal hemangioblastomas, pancreatic tumors and cysts, endolymphatic sac tumors, and cystadenomas of the epididymis and broad ligament (NIH, 2024). ... |
|
|
Thyroid Eye Disease Mastery: Multidisciplinary Approaches to Diagnosis and Treatment
Thyroid eye disease (TED) is a multifactorial autoimmune disease with widely varied signs and symptoms. It is believed to result from the stimulation of several receptors located in the orbital fibroblasts and is usually associated with hyperthyroidism. However, 5% of patients with TED have hypothyroidism, and 5% have no sign of thyroid disease; thus, it is frequently misdiagnosed. Misdiagnosis can place patients at risk for disfigurement and permanent vision loss, because treatment is most ef... |
|
|
Neuroinflammation in Alzheimer’s Disease: Implications for Early Detection and Treatment
Alzheimer’s disease (AD) is an irreversible, age-related neurodegenerative disorder characterized by a gradual decline in understanding, memory, and ability to perform activities of daily living. With the recent approval of novel AD treatments and the evolving therapeutic landscape, it is imperative for clinicians to stay informed on the current issues surrounding AD. This CE program "Neuroinflammation in Alzheimer’s Disease: Implications for Early Detection and Treatment" aims t... |
|
|
Neuroinflammation in Alzheimer’s Disease: Implications for Early Detection and Treatment
Alzheimer’s disease (AD) is an irreversible, age-related neurodegenerative disorder characterized by a gradual decline in understanding, memory, and ability to perform activities of daily living. With the recent approval of novel AD treatments and the evolving therapeutic landscape, it is imperative for clinicians to stay informed on the current issues surrounding AD. This CE program "Neuroinflammation in Alzheimer’s Disease: Implications for Early Detection and Treatment" aims t... |
|
|
Psoriasis Prime Time: TYK Inhibition in Hard-to-Treat Psoriasis
Target Audience
This activity has been designed to address the educational needs of dermatologists, dermatology nurse practitioners, and PAs. It may also be of benefit to primary care clinicians, rheumatologists, and other healthcare practitioners who are interested in the treatment of psoriasis.
Program Overview
In this edition of Psoriasis Prime Time, the faculty reviews the use of allosteric tyrosine kinase 2 (TYK2) inhibitors in the treatment of hard-to-treat psoriasis, including the ... |
|
|
Occurrence and Disease Course of RSV Illness in Adults
Target Audience
This educational activity is intended for US-based healthcare professionals who care for older adults, including pulmonologists, geriatricians, and additional primary care providers (family physicians, internists, physician associates, nurse practitioners and other nursing professionals, and pharmacists).
Program Overview
Respiratory syncytial virus (RSV) is a highly contagious seasonal lower respiratory tract infection (LRTI) characterized by cough, runny nose, sneezing, ... |
|
|
9th Annual Internal Medicine in Primary Care Conference
Prepare to embark on an extraordinary voyage of discovery and rejuvenation aboard the Celebrity Edge, where the 9th Annual Internal Medicine in Primary Care Conference awaits amidst the awe-inspiring landscapes of Alaska. From July 25 to August 1, 2025, immerse yourself in the natural splendor of the Inside Passage as you sail through pristine fjords, past towering glaciers, and alongside majestic wildlife. This unique cruise offers a perfect blend of educational enrichment and leisurely explo... |
|
|
DETECT" Advances in the Delayed-Onset of Type 1 Diabetes: Strategies to Improve Awareness and Care for the Practicing Clinician
Target Audience
This activity is designed to meet the educational needs of Pediatric Endocrinologists, Adult Endocrinologists, Pediatricians, Primary Care Providers (PCPs), and Endocrine Nurses.
Program Overview
This educational program focuses on the early screening, detection, and advances in the treatment of early-stage type 1 diabetes (T1D). Through this enduring Grand Rounds session, clinicians will be able to review the importance and benefits of early screening, how to screen &... |
|
|
Establishing Frameworks for Precision Medicine in NTRK Fusion-Positive Advanced Solid Tumors
Despite significant advancements over the past decade, significant unmet needs persist for patients with NTRK-positive locally advanced or metastatic solid tumors. In addition, there is ongoing debate about the importance of testing for genomic alterations in rare cancers, or those that rarely occur in common cancers. However, evolving molecular testing procedures and emerging therapeutic options targeting NTRK fusions offer new pathways for the detection and treatment of these cancers. To he... |
|
|
Management of Metastatic Colorectal Cancer
Stacey Cohen, MD, explores the significance of molecular profiling and tumor markers in personalizing immunotherapy for metastatic colorectal cancer. She also delves into the evolving landscape of targeted therapies, discussing the nuances and considerations of different options to optimize patient outcomes. |
|
|
Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 1
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all cancer deaths in the United States, and even among cancers that do have standard tests, factors such as low awareness, lack of available facilities, and in... |
|
|
Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 2
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). Multicancer early detection (MCED) is an emerging form of blood-based testing that utilizes cancer biomarkers in the blood to screen for multiple cancers simultaneously (ACS, 2024). Currently, numerous clinical trials are investiga... |
|
|
Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 3
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all cancer deaths in the United States (ACS, 2024; Pinsky & Berg, 2012; USPSTF, 2024). Multicancer early detection (MCED) is a novel form of blood-based ca... |
|
|
Podcast - Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 1
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all cancer deaths in the United States, and even among cancers that do have standard tests, factors such as low awareness, lack of available facilities, and in... |
|
|
Podcast - Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 2
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all cancer deaths in the United States, and even among cancers that do have standard tests, factors such as low awareness, lack of available facilities, and in... |
|
|
Podcast - Optimizing Cancer Screening With MCED Technologies: From Science to Practical Application - Module 3
STATEMENT OF NEED
Approximately 2 million new cancer cases are expected in the United States in 2024, with an anticipated 611,720 deaths (ACS, 2024). Screening is associated with earlier stage at diagnosis and improved outcomes (Kim et al, 2011; Plumb et al, 2016). However, cancers that are not routinely screened for account for 78% of all cancer deaths in the United States, and even among cancers that do have standard tests, factors such as low awareness, lack of available facilities, and in... |
|
|
Musculoskeletal Ultrasound: Advanced Interventions & Regenerative Medicine - Live Course
The Musculoskeletal Ultrasound: Advanced Interventions & Regenerative Medicine Training Course is taught by leading experts in the field of MSK ultrasound. This course takes your musculoskeletal ultrasound skills to the next level with a focus on advanced diagnostic and interventional skills including spine, peripheral nerve, tendinopathy and ultrasound-guided tenotomy. Regenerative medicine applications including prolotherapy, platelet-rich plasma (PRP), bone-marrow aspirate concentrate (... |
|
|
Advances In the Delayed-Onset of Type 1 Diabetes: Strategies to Improve Awareness and Care for the Practicing Clinician - Part 3
Target Audience
This activity is designed to meet the educational needs of Pediatric and Adult Endocrinologists, Pediatricians, Primary Care Providers, and Endocrine Nurses.
Program Overview
During this program, experts will present overviews of the importance of early screening and staging for type 1 diabetes (T1D), strategies and practical pearls for screening and follow-up, how to intervene early with disease-modifying therapies to delay progression to clinical T1D, as well as ongoing ... |
|
|
Mastering Suboptimal Treatment Response in nAMD
In this Master Class case, Dr. David Eichenbaum discusses the management of a 69-year-old White man with neovascular age-related macular degeneration who receives a suboptimal treatment response to initial anti-vascular epithelial growth factor therapy. |
|
|
Recognizing and Confirming Potential ATTR in Your Patients
Target Audience
This activity is designed to meet the educational needs of physicians, allied health practitioners, and students interested in complex cardiovascular and thoracic conditions and those who care for patients with ATTR.
Program Overview
This activity will cover early diagnosis and intervention for transthyretin amyloidosis (ATTR), which is critical, yet does not occur, typically as a consequence of the rarity and heterogeneity of the disease and limited awareness on the part ... |
|
|
Navigating the Evolving Standards of Newly Diagnosed Multiple Myeloma Treatment: Exploring the Evidence on New Combination Strategies
ACTIVITY DESCRIPTION
The goal of treatment for newly diagnosed multiple myeloma (NDMM) patients is achieving the deepest possible remission, which typically involves aiming for minimal residual disease negativity. Frontline therapy for NDMM is evolving to include novel induction regimens with anti-CD38 antibodies, which have been shown to yield improved depth of response after induction. These new frontline treatments vary in induction regimen composition and use of transplant, consolidation,... |
|
|
ASCVD Clinical Research Updates Targeting Residual Inflammation in Patients with ASCVD and CKD
Emerging evidence and scientific advancements are revealing pathophysiologic mechanisms correlated with systemic inflammation and the development of atherosclerotic cardiovascular disease (ASCVD). Patients with chronic kidney disease (CKD) are at high risk for developing ASCVD. Novel anti-inflammatory therapies are showing efficacy at reducing inflammation and development of ASCVD, and are adding to the treatment options beyond the usual lipid-lowering agents. As new clinical evidence and tar... |
|
|
Improving the Diagnosis and Management of Pulmonary Progressive Fibrosis (PPF): A Focus on Systemic Sclerosis Interstitial Lung Disease (SSc-ILD) and Idiopathic Pulmonary Fibrosis (IPF)
Target Audience
This activity is designed to meet the educational needs of rheumatologists, pulmonologists, and advanced practice providers.
Program Overview
This activity features an interactive case-based format where you can review questions to determine best practices in diagnosing and managing PPF, SSc-ILD, and IPF. This session offers real-life examples to help differentiate diseases within the Pulmonary Progressive Fibrosis (PPF) group, such as Idiopathic Pulmonary Fibrosis (IPF) a... |
|
|
Clinical Competence in Cardiac CT Compendium
Supplemented with all new presentation content and worth up to 60.5 AMA PRA Category I Credits™, the Clinical Competence in Cardiac CT Compendium will help meet credentialing and/or maintenance requirements for Cardiac CT. Each case features a simulated workstation, with hundreds of datasets of fully navigable imagines, supplement diagnostic materials and detailed description of findings by expert faculty. The cases present a wide variety of cardiovascular pathology, including the assessme... |
|
|
Bunion-Like Toes and Tumor Like Swellings " Recognize FOP and Improve Patient Outcomes in the Era of Disease Specific Therapy
Target Audience
This activity is designed to meet the educational needs of healthcare providers in pediatrics, primary care, oncology, surgery, radiology, acute care, emergency medicine, rheumatology, and infectious disease.
Program Overview
Bunion-like toes present at birth and tumor-like swellings in a young child are diagnostic signs of fibrodysplasia ossificans progressive (FOP), a disease with recent advances made in therapy. Upon completion of the course, learners should be able to ... |
|
|
Podcast: Multidisciplinary Task Force and Position Statement: Mitigating Disease Burden and Health Care Disparities in Relapsed/Refractory Multiple Myeloma
STATEMENT OF NEED
With the complex and rapidly evolving treatment landscape of multiple myeloma, it is vital that clinicians not only understand factors for informing selection of current and emerging combination and sequential therapeutic strategies, but also employ interdisciplinary strategies for reducing disparities in relapsed/refractory multiple myeloma care. The development of novel therapeutic options has significantly improved treatment outcomes for patients with relapsed/refractor... |
|
|
Defining the therapeutic algorithm in patients with HR positive breast cancer - United States
Target Audience
The initiative will target oncology clinicians in the US, Germany, Spain, Italy, and France, and specifically those actively involved in the treatment of breast cancer
Learning Objectives
Upon completion of this activity, participants should be better able to:
Assess the efficacy of new target therapy options in the management of patients with HR + early and metastatic BC with and implications for team-based and shared decision-making globall
Apply the most recent evid... |
|